Perspectives on the development of imatinib and the future of cancer research

被引：76

作者：

Druker, Brian J. ^{[1
,2
,3
]}

机构：

[1] Howard Hughes Med Inst, Portland, OR USA

[2] Leukemia Res, Portland, OR USA

[3] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA

来源：

NATURE MEDICINE | 2009年 / 15卷 / 10期

关键词：

CLINICAL-TRIALS; LUNG-CANCER; MUTATIONS; MESYLATE; TUMORS;

D O I：

10.1038/nm1009-1149

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页码：1149 / 1152

页数：4

共 23 条

[1] Long-term results from a randomized phase II trial of standard- versus higher-dose imatinib mesylate for patients with unresectable or metastatic gastrointestinal stromal tumors expressing KIT [J].

Blanke, Charles D. ;

Demetri, George D. ;

von Mehren, Margaret ;

Heinrich, Michael C. ;

Eisenberg, Burton ;

Fletcher, Jonathan A. ;

Corless, Christopher L. ;

Fletcher, Christopher D. M. ;

Roberts, Peter J. ;

Heinz, Daniela ;

Wehre, Elisabeth ;

Nikolova, Zariana ;

Joensuu, Heikki .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (04) :620-625

[2] Comprehensive genomic characterization defines human glioblastoma genes and core pathways [J].

Chin, L. ;

Meyerson, M. ;

Aldape, K. ;

Bigner, D. ;

Mikkelsen, T. ;

VandenBerg, S. ;

Kahn, A. ;

Penny, R. ;

Ferguson, M. L. ;

Gerhard, D. S. ;

Getz, G. ;

Brennan, C. ;

Taylor, B. S. ;

Winckler, W. ;

Park, P. ;

Ladanyi, M. ;

Hoadley, K. A. ;

Verhaak, R. G. W. ;

Hayes, D. N. ;

Spellman, Paul T. ;

Absher, D. ;

Weir, B. A. ;

Ding, L. ;

Wheeler, D. ;

Lawrence, M. S. ;

Cibulskis, K. ;

Mardis, E. ;

Zhang, Jinghui ;

Wilson, R. K. ;

Donehower, L. ;

Wheeler, D. A. ;

Purdom, E. ;

Wallis, J. ;

Laird, P. W. ;

Herman, J. G. ;

Schuebel, K. E. ;

Weisenberger, D. J. ;

Baylin, S. B. ;

Schultz, N. ;

Yao, Jun ;

Wiedemeyer, R. ;

Weinstein, J. ;

Sander, C. ;

Gibbs, R. A. ;

Gray, J. ;

Kucherlapati, R. ;

Lander, E. S. ;

Myers, R. M. ;

Perou, C. M. ;

McLendon, Roger .

NATURE, 2008, 455 (7216) :1061-1068

[3] Accrual to clinical trials at selected comprehensive cancer centers [J].

Dilts, D. M. ;

Sandler, A. B. ;

Cheng, S. ;

Crites, J. ;

Ferranti, L. ;

Wu, A. ;

Bookman, M. A. ;

Thomas, J. P. ;

Ostroff, J. .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)

[4] Processes to activate phase III clinical trials in a cooperative oncology group: The case of Cancer and Leukemia Group B [J].

Dilts, David M. ;

Sandler, Alan B. ;

Baker, Matthew ;

Cheng, Steven K. ;

George, Stephen L. ;

Karas, Kathleen S. ;

McGuire, Stephen ;

Menon, Gourija S. ;

Reusch, Jason ;

Sawyer, Debbie ;

Scoggins, Maren ;

Wu, Amy ;

Zhou, Kai ;

Schilsky, Richard L. .

JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (28) :4553-4557

[5]

Druker BJ., 2001, NEW ENGL J MED, V344, P10311037

[6] Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia [J].

Druker, Brian J. ;

Guilhot, Francois ;

O'Brien, Stephen G. ;

Gathmann, Insa ;

Kantarjian, Hagop ;

Gattermann, Norbert ;

Deininger, Michael W. N. ;

Silver, Richard T. ;

Goldman, John M. ;

Stone, Richard M. ;

Cervantes, Francisco ;

Hochhaus, Andreas ;

Powell, Bayard L. ;

Gabrilove, Janice L. ;

Rousselot, Philippe ;

Reiffers, Josy ;

Cornelissen, Jan J. ;

Hughes, Timothy ;

Agis, Hermine ;

Fischer, Thomas ;

Verhoef, Gregor ;

Shepherd, John ;

Saglio, Giuseppe ;

Gratwohl, Alois ;

Nielsen, Johan L. ;

Radich, Jerald P. ;

Simonsson, Bengt ;

Taylor, Kerry ;

Baccarani, Michele ;

So, Charlene ;

Letvak, Laurie ;

Larson, Richard A. .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (23) :2408-2417

[7] Translation of the Philadelphia chromosome into therapy for CML [J].

Druker, Brian J. .

BLOOD, 2008, 112 (13) :4808-4817

[8] Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers [J].

Engelman, Jeffrey A. ;

Chen, Liang ;

Tan, Xiaohong ;

Crosby, Katherine ;

Guimaraes, Alexander R. ;

Upadhyay, Rabi ;

Maira, Michel ;

McNamara, Kate ;

Perera, Samanthi A. ;

Song, Youngchul ;

Chirieac, Lucian R. ;

Kaur, Ramneet ;

Lightbown, Angela ;

Simendinger, Jessica ;

Li, Timothy ;

Padera, Robert F. ;

Garcia-Echeverria, Carlos ;

Weissleder, Ralph ;

Mahmood, Umar ;

Cantley, Lewis C. ;

Wong, Kwok-Kin .

NATURE MEDICINE, 2008, 14 (12) :1351-1356

[9]

Flaherty K, 2009, J CLIN ONCOL, V27

[10] ONCOGENES, GROWTH-FACTORS, AND SIGNAL TRANSDUCTION [J].

FLIER, JS ;

DRUKER, BJ ;

MAMON, HJ ;

ROBERTS, TM .

NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (20) :1383-1391

← 1 2 3 →